ClouDr Group Limited
9955.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$319.63M
Close$
Share Statistics
| Market cap | $319.63 Million |
|---|---|
| Enterprise Value | $289.27 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.52 |
| Beta | 0.3 |
| Outstanding Shares | 596,200,000 |
Return
| Return on Equity | -79.23% |
|---|---|
| Return on Assets | -27.55% |
| Return on Invested Capital | -5.78% |
Valuation & Multiples
| P/E Ratio | -0.65 |
|---|---|
| PEG | 0.69 |
| Price to Sales | 0.22 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.21 |
| Enterprise Value to EBIT | -10.5 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.73 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$363.38 M
Average shareholder expectationNext Earnings Call
Expected Date
March 25, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ClouDr Group Limited
776 employees
CEO: Ming Kuang ClouDr Group Limited operates as an investment holding company, providing a diverse range of services within the healthcare sector. The firm supplies hospitals and pharmacies with crucial medical products, including devices like blood gl...